CME Q3 2026 Earnings: Record Volume Drives 13% Revenue Growth

CME Group (NASDAQ: CME) reported Q3 2026 revenue of $1.737 billion, approximately 13% higher than $1.538 billion a year earlier, while diluted EPS rose to $2.89 from $2.49 for the quarter ended September 30. Record third-quarter average daily volume and 20% market data revenue growth supported the results, while revenue growth outpaced expense growth and expanded the GAAP operating margin.

Core Financial Results

CME generated its highest third-quarter revenue on record. Total expenses increased approximately 5.5%, slower than revenue, helping GAAP operating income rise about 17.4% and the operating margin expand by approximately 2.4 percentage points.

Adjusted results also improved, although adjusted net income and EPS grew more slowly than GAAP operating income. The principal adjustments included purchased-intangible amortization, restructuring and severance, and several smaller items.

Trading Activity and Revenue Mix

Clearing and transaction fees increased approximately 12.2% to $1.378 billion, remaining CME’s largest revenue source. Market data and information services revenue rose 20% to a record $243.1 million, while other revenue increased to $116.1 million from $107.2 million.

Average daily volume reached a third-quarter record of 29.445 million contracts, approximately 16.3% above the prior-year period. All six asset classes recorded double-digit volume growth, with equity indexes posting the largest percentage increase.

Non-U.S. average daily volume also reached a third-quarter high of 9 million contracts, indicating that the increase was not limited to domestic trading activity.

Higher Volume Offset a Lower Rate per Contract

CME’s total average rate per contract declined to $0.679 from $0.702, a decrease of approximately 3.3%. Despite that decline, clearing and transaction fees rose more than 12% because the increase in contract volume was substantially larger.

The relationship indicates that trading activity, rather than higher revenue per contract, was the primary driver of transaction revenue growth. CME notes that the rate per contract can vary with product, venue and customer mix, as well as incentive programs, but the release did not identify one specific factor behind the quarter’s decline. The 20% increase in market data revenue provided an additional source of growth outside transaction fees.

Profitability, Capital, and the Balance Sheet

Revenue growth exceeded the increase in operating costs. Among major expense categories, technology expense rose to $80.9 million from $71.4 million, and licensing and other fee-agreement expense increased to $104.2 million from $81.6 million. Compensation and benefits declined slightly to $234.3 million from $237.6 million.

CME ended September with $2.4 billion in cash, including $225 million deposited with the Fixed Income Clearing Corporation, and $3.4 billion of debt. The company returned nearly $1 billion to shareholders during the quarter through $465 million of regular dividends and $524 million of share repurchases.

Management Commentary

Chairman and CEO Terry Duffy attributed the trading increase to intensified uncertainty that prompted clients to manage risk and pursue market opportunities through CME’s products. Management also highlighted a new high of $100 billion in average daily capital efficiencies.

CME reported progress on its cloud migration and said its infrastructure now gives clients a choice between co-location and cloud-managed services. This initiative is intended to broaden access, although the company also identifies migration expenses, duplicated on-premise and cloud costs, and technology reliability as execution considerations.

Recent Insider Transactions

The source’s six-month summary lists 19,807 shares across 22 purchase-category transactions and 56,253 shares across four sales, resulting in net sales of 36,446 shares. Because the detailed records include stock awards alongside purchases and sales, the transaction type is important when interpreting the figures.

Risks Investors Need to Watch

• Trading activity may normalize: Q3 growth depended heavily on higher contract volume during a period of intensified uncertainty. Lower trading and clearing activity would directly affect CME’s largest revenue category.
• Revenue per contract declined: The average rate per contract fell year over year. Further unfavorable changes in product or customer mix, pricing, or incentives could limit transaction revenue growth even if volume remains elevated.
• Cloud migration carries cost and execution risk: Maintaining cloud and on-premise environments during the transition can create duplicated or variable costs, while platform reliability remains critical at record trading volumes.
• Market data growth may not persist: Market data revenue reached a record and grew 20%, but changes in customer demand or regulation could affect this increasingly important revenue stream.

Summary

CME’s Q3 2026 results were driven by record third-quarter trading volume across a broad range of asset classes and a 20% increase in market data revenue. Higher activity more than offset a lower average rate per contract, while operating expenses grew more slowly than revenue and supported margin expansion. Future results will depend on whether trading activity remains elevated, how revenue per contract develops, and whether CME can execute its cloud migration without disproportionate cost or operational pressure.